학술논문
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial
Document Type
Article
Author
Source
In Chest July 2022 162(1):46-55
Subject
Language
ISSN
0012-3692